Insight journal - Company

Bristol-Myers Squibb: M&A activity 2005-2013

Posted on 18 March 2013

Tags: , ,

Bristol-Myers Squibb (BMS) has announced 9 M&A deals since 2005, with the lead deals being the acquisitions of Amylin, Inhibitex and Medarex.

Abstracted from: Partnering Deals and Alliances with Bristol-Myers Squibb

Bristol-Myers Squibb has a steady record of growth through acquisition, with an average of one to two major acquisition every year, although 2012 was particularly busy with three major acquisitions.

The following figure shows the level of BMS M&A deal announcements since 2005.

Figure 1: Bristol-Myers Squibb M&A deals 2005-2012

BMS M and A by year

Source: Current Agreements, 2013

Bristol-Myers Squibb has signed 9 M&A deals since 2005. Companies acquired include:

  • Amira
  • Amylin Pharmaceuticals
  • Inhibitex
  • Medarex
  • Kosan Biosciences
  • Zymogenetics

View the full list at Current Agreements (subscription required)

Bristol-Myers Squibb has been attracted to growth through acquisition in order to build its biotechnology expertise and product pipeline, resulting in a business with a leading position in this market.

The following figure provides a summary of the top M&A deals by headline value.

Figure 2: Top Bristol-Myers Squibb M&A deals by headline value 2005-2013

BMS M and A deals by value

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Bristol-Myers Squibb

Bristol-Myers Squibb M&A at Current Agreements 

View all M&A deals for Bristol-Myers Squibb: 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Deals and Alliances with Bristol-Myers Squibb

More

Summary profile data for BMS

Partnering interests for BMS

Partnering activity for BMS

 

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Bristol-Myers Squibb

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Bristol-Myers Squibb

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Bristol-Myers Squibb company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

 

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply